Employee Recognition: Awards, Tributes, and Fun umaryland.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umaryland.edu Daily Mail and Mail on Sunday newspapers.
WHAT WE FOUND
Activated charcoal is a “highly adsorbent, fine, black, odorless, tasteless powdered charcoal used in medicine, especially as an antidote in many forms of poisoning and as an antiflatulent,” according to Merriam-Webster’s Medical Dictionary.
Canadian pharmacologist Dr. David Juurlink wrote in 2015 that French chemist Michel Bertrand was reportedly the first person to ingest activated charcoal as an antidote in 1811 after consuming five grams of arsenic trioxide. Since then, activated charcoal has mostly been used by healthcare professionals to treat overdose and poison patients.
Dr. Bruce Anderson, the executive director of the Maryland Poison Center and professor of pharmacy practice and science at the University of Maryland School of Pharmacy in Baltimore, broke down how activated charcoal is created.
Apr 21, 2021
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
A study of more than 2,500 hospital patients discharged to hospice care over a nine-year period showed a decreasing trend of opioid prescriptions as well as an increase in the prescribing of less powerful, non-opioid analgesics, meaning some of those patients might have been undertreated for their pain compared to similar patients in prior years.
The findings, published in the Journal of Pain and Symptom Management, are an important step toward optimizing pain management and minimizing the suffering of dying patients. Hospice care refers to treatments whose goal is to maximize comfort and quality of life as opposed to prolonging life.
Apr 21, 2021
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
A study of more than 2,500 hospital patients discharged to hospice care over a nine-year period showed a decreasing trend of opioid prescriptions as well as an increase in the prescribing of less powerful, non-opioid analgesics, meaning some of those patients might have been undertreated for their pain compared to similar patients in prior years.
The findings, published in the Journal of Pain and Symptom Management, are an important step toward optimizing pain management and minimizing the suffering of dying patients. Hospice care refers to treatments whose goal is to maximize comfort and quality of life as opposed to prolonging life.
Apr 21, 2021
Policies designed to prevent the misuse of opioids may have the unintended side effect of limiting access to the pain-relieving drugs by terminally ill patients nearing the end of their life, new research led by the Oregon State University College of Pharmacy suggests.
A study of more than 2,500 hospital patients discharged to hospice care over a nine-year period showed a decreasing trend of opioid prescriptions as well as an increase in the prescribing of less powerful, non-opioid analgesics, meaning some of those patients might have been undertreated for their pain compared to similar patients in prior years.
The findings, published in the Journal of Pain and Symptom Management, are an important step toward optimizing pain management and minimizing the suffering of dying patients. Hospice care refers to treatments whose goal is to maximize comfort and quality of life as opposed to prolonging life.